March, 2011

Gemini Investors is pleased to announce its recent investment in Wake Research Associates.  Wake, based in Raleigh, NC, is a dedicated research site, conducting clinical trials for many of the largest pharmaceutical and biomedical sponsors, and Clinical Research Organizations.  With well over 2,000 clinical trials completed to date, Wake has developed exceptional recruitment and data collection practices, resulting in the recruitment, screening and enrollment of hundreds of patients each year for Phase II-IV trials in a diverse range of therapeutic areas.

About Gemini Investors

Gemini Investors, an investment firm located in Wellesley, MA manages four private equity funds with total committed capital of $450 million. We are focused on shareholder liquidity, management buyouts, acquisition financing, and growth capital transactions with established companies led by experienced management teams. Gemini typically invests $3 – $8 million per transaction in either control or minority positions. Since 1993, we have invested in 75+ companies across the U.S. in numerous industry sectors, including business services, healthcare, education, waste and recycling, consumer services, manufacturing, distribution, and later stage technology. The U.S. Small Business Administration honored Gemini Investors as the 2009 Small Business Investment Company of the Year.

For more information about Gemini please contact:

Rob Menn at (781) 237-7001  |  rmenn@gemini-investors.com